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Retrotransposons are endogenous genomic sequences that have had a central role in shaping our genome and the genomes from other mammals over millions of years. 
In fact, approximately 45% of the human genome is comprised of interspersed repeats resulting from replicative copy and paste events of retrotransposons. Although 
most of these sequences represent fossils of previously active retroelements, each eukaryote has a specific complement of recently active transposable elements, posing 
a threat to genomic stability throughout all cellular populations due to retrotransposition events. In response, mammals have developed intrinsic immunity mechanisms 
that provide resistance against the deleterious effects of retrotransposition. This final project is a review of the most important known mechanisms that human and 
mouse have to protect their genomes against the deleterious effects caused by, virtually, the unique mobile elements that are currently active and that are these of the 
non-LTR retrotransposons subgroup: LINE1 and their non autonomous partners SVA and Alu. 
REGULATORY MECHANISMS: 
Fig 3. Schematic representation of the structural 
organization of human SVA.  
Fig 2. Schematic representation of the structural 
organization of human Alu (SINE). 
Fig 1. Schematic representation of the structural 
organization of human L1 (LINE-1). 
CONCLUSION: 
DNA methyltransferases 
Fig 4. A) B) C) D) Effects of mutations of piRNAs (Pld6) and DNA 
methyltransferases on de novo B1 methylation. E) Fold reductions in 
individual B1 methylation due to mutations. F) Fold reductions in 
methylation due to Dnmt3a KO mutation at individual B1 loci (dark grey 
circles), B1 loci selected from SINE-poor domains (light grey circles) and 
the methylation levels at three methylated regions for genomic imprinting 
in wt and Dnmt3a spermatogonia (open squares).  
MOV10 RNA Helicase 
Fig 7. Evidence from cell culture retrotransposition assays that 
MOV10 inhibits insertion of non-LTR retrotransposons. 
piRNA-PIWI system 
Fig 6. Transposon silencing in mouse spermatogenesis. 
Upper part: shows the stages of spermatogenesis and when the 
three piRNAs groups are expressed. Lower part: Horizontal 
thick lines show the expression periods of genes indicated 
(DNMT3L, MILI, MIWI2, MIWI and MAEL) during 
spermatogenesis. Red crosses show the time points when loss 
of individual genes shows phenotypic abnormality. How 
transposon and DNA methylation are affected when individual 
genes are abrogated in their mutant mice is summarized on the 
right-hand size.  
Fig 5. Formation of piRNAs in mouse by a 
Ping-pong amplification. piRNA clusters are not 
the major source of primary piRNAs. mRNAs of 
active transposable elements likely represent the 
substrate for primary processing resulting in sense 
piRNAs that preferentially associate with MILI, 
whereas MIWI2 is specifically enriched in secondary 
antisense piRNAs as compared to MILI. Antisense 
piRNAs guide DNA methylation of transposable 
elements. 
APOBEC family 
Human (primate) Mouse (rodent) 
Fig 8. A schematic representation of the human 
genome containing members of the AID/APOBEC family. 
Fig 9. A schematic representation of the murine genome 
containing members of the AID/APOBEC family. 
Fig 10. Inhibition of L1 retrotransposition by 
APOBEC proteins in 293T cells. Relative 
retrotransposition frequency in the absence of APOBEC 
proteins (vector) was set as 1.0. 
Fig 11. Transposition frequency of L1 in 293T cells 
along with the expression plasmids for APOBEC family 
proteins. Amounts of APOBEC-expression plasmids were 
varied (0.5, 0.25 and 0.125 μg). 
These regulatory mechanisms are essential to protect human and 
mouse genomes of the deleterious effects caused by 
retrotransposons.  
 
Most of them act in the germline, which is where transposons are 
more active due to the many germline-specific genes being expressed. 
 
Despite retrotransposition’s negative effect, cellular machineries have 
evolved to support a balance between retrotransposition insertions 
that cause deleterious gene disruption and those that confer beneficial 
genetic diversity, and a regulatory mechanism. 
 
However, it is still a long way to learn and understand how these and 
other regulatory mechanisms inhibit retrotransposition in mammals. 
 
More functional genomic screens and better in vitro retrotransposition 
assays are needed, to determine precisely where and how host factors 
interact with the retrotransposons molecular machinery, to block their life 
cycle. 
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INTRODUCTION: 
